Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000547328 | SCV000652230 | uncertain significance | Neonatal-onset encephalopathy with rigidity and seizures | 2022-08-05 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with BRAT1-related conditions. ClinVar contains an entry for this variant (Variation ID: 472944). Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. This variant is present in population databases (rs539902160, gnomAD 0.0009%). This sequence change replaces isoleucine, which is neutral and non-polar, with phenylalanine, which is neutral and non-polar, at codon 494 of the BRAT1 protein (p.Ile494Phe). |
Ambry Genetics | RCV004965564 | SCV005548511 | uncertain significance | Inborn genetic diseases | 2024-10-09 | criteria provided, single submitter | clinical testing | The c.1480A>T (p.I494F) alteration is located in exon 11 (coding exon 10) of the BRAT1 gene. This alteration results from a A to T substitution at nucleotide position 1480, causing the isoleucine (I) at amino acid position 494 to be replaced by a phenylalanine (F). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |